Ascorbic acid market seen topping $2 billion by 2030

The Business Research Company says the global ascorbic acid market is set to pass $2 billion by 2030, led by calcium ascorbate and sodium ascorbate. The report points to stronger demand from supplements, pharmaceuticals, clean-label foods and personal care, with Asia Pacific and China expected to anchor growth.

Why it matters: - The ascorbic acid market is expected to add more than $0.7 billion in value by 2030 from calcium ascorbate, sodium ascorbate and other product forms. - The forecast points to steady demand across food, pharmaceuticals, cosmetics and personal care, with implications for ingredient suppliers and manufacturers. - The market’s growth comes as buyers want cleaner labels, higher bioavailability and more stable vitamin C formats.

What happened: - The Business Research Company released its 2026 ascorbic acid market report on Oct. 16, 2026. - The report forecasts the global ascorbic acid market will surpass $2 billion by 2030. - The report says the market will grow at a 7% compound annual growth rate through 2030. - Calcium ascorbate and sodium ascorbate are each projected to add $0.2 billion in value by 2030. - The other major forms — magnesium ascorbate, potassium ascorbate and D-isoascorbic ascorbate — are each projected to add about $0.1 billion.

The details: - Calcium ascorbate is projected to hold a 32% share of the market in 2030, worth about $1 billion. - The report says calcium ascorbate is favored in dietary supplements because it is a non-acidic vitamin C source. - Demand for calcium ascorbate is rising in mineral-fortified foods, functional beverages and formulations that emphasize stability and bioavailability. - Asia Pacific is expected to be the largest regional market by 2030, reaching $1.0 billion from $0.7 billion in 2025. - China is forecast to be the largest national market by 2030, with revenue of $0.5 billion, up from $0.3 billion in 2025. - The report says China benefits from large production capacity, export strength and rising domestic demand. - The market is split by grade into pharmaceutical, food and other categories. - Distribution runs through online and offline retail channels. - Applications include food and beverages, pharmaceuticals, cosmetics, chemicals, agriculture and other uses. - The report names BASF SE, Koninklijke DSM N.V., Northeast Pharmaceutical Group Co. Ltd., CSPC Pharmaceutical Group, North China Pharmaceutical Group, Sigma-Aldrich Corporation, Amway Corporation, Glanbia PLC, Bactolac Pharmaceutical Inc. and LabChem Inc. among the key players. - BASF SE had the largest global sales share in 2024 at 2%. - Other active companies include Bayer AG, The Bountiful Company, Tirlán Co-operative Society Limited, Nutrilo GmbH, Archer-Daniels-Midland Company, Foodchem International Corporation, LGM Pharma LLC, Muby Chemicals Pvt. Ltd., Huachang Pharmaceuticals, Changsha Natureway Co. Ltd. and Homart Pharmaceuticals Pty Ltd.

Between the lines: - The market remains fragmented, with the top 10 companies accounting for only 8% of revenue in 2024. - Moderate entry barriers come from strict food and pharmaceutical quality standards, complex production processes and the need for reliable supply chains. - Leading companies are leaning on product diversification, global networks and innovation to defend share. - Competition is intensifying as manufacturers push advanced production techniques, improved formulations and cleaner-label offerings. - Nutricosmetics and skin care are adding demand as vitamin C is used for antioxidant benefits and collagen production. - Pharmaceutical use is expanding as ascorbic acid is used in nutritional and therapeutic dosage forms for immune support and preventive care. - Clean-label demand is pushing food and nutrition brands to use ascorbic acid for antioxidant and preservative functions. - High-dose injectable ascorbic acid is emerging as a niche category for antioxidant therapy, immune support and clinical applications. - In July 2025, Oncofit Solutions launched Ascotfit - HD, a 25-gram injectable vitamin C product for clinical oncology, anti-aging and regenerative medicine.

What's next: - The report expects end-market demand to keep building across fortified nutrition, pharmaceuticals and personal care products. - Asia Pacific and China are expected to remain key growth engines through 2030. - The report says technological upgrades, capacity expansions and stricter quality control will remain central competitive tools. - The Business Research Company says its 2026 reports add market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspot infographics and updated graphics and tables. - More information is available in the company's announcement.